A recent study evaluated IGF1R-targeted CAR-T cells in sarcomas and found that IGF1R-targeted CAR-T cells remarkedly reduced tumor growth in pre-established, localized, and systemically disseminated OS mouse models. The gene discussed is IGF1R; the disease is neoplasm.